ASB Consultores’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-1,818
Closed -$278K 83
2025
Q2
$278K Buy
1,818
+91
+5% +$14K 0.19% 97
2025
Q1
$286K Sell
1,727
-3,856
-69% -$603K 0.19% 80
2024
Q4
$807K Buy
5,583
+522
+10% +$80.9K 0.34% 49
2024
Q3
$820K Buy
5,061
+248
+5% +$39.5K 0.32% 50
2024
Q2
$703K Sell
4,813
-2,972
-38% -$442K 0.25% 48
2024
Q1
$1.23M Buy
7,785
+5,177
+199% +$824K 0.32% 38
2023
Q4
$409K Sell
2,608
-1,953
-43% -$299K 0.14% 55
2023
Q3
$710K Sell
4,561
-4,273
-48% -$705K 0.28% 37
2023
Q2
$1.46M Buy
8,834
+263
+3% +$42.4K 0.71% 22
2023
Q1
$1.33M Buy
8,571
+1,389
+19% +$224K 0.53% 28
2022
Q4
$1.27M Sell
7,182
-651
-8% -$112K 0.52% 25
2022
Q3
$1.28M Buy
7,833
+668
+9% +$113K 0.6% 24
2022
Q2
$1.27M Buy
7,165
+3,369
+89% +$600K 0.55% 21
2022
Q1
$673K Hold
3,796
0.28% 56
2021
Q4
$649K Buy
+3,796
New +$621K 0.32% 59

Other funds holding JNJ

ASB Consultores's JNJ Position: Q3 2025 in Review

ASB Consultores sold out of Johnson & Johnson (JNJ) in Q3 2025, closing a stake of 1,818 shares — an estimated $278K sold.

ASB Consultores first reported a position in JNJ in Q4 2021 and held it in 15 quarters. The position peaked at $1.46M in Q2 2023. 4,187 funds tracked by Wall St. Rank hold JNJ as of Q3 2025.

  • ASB Consultores reported no remaining Johnson & Johnson position as of Q3 2025 after selling out during the quarter.
  • ASB Consultores sold 1,818 Johnson & Johnson shares in Q3 2025, an estimated $278K.
  • ASB Consultores first reported a position in Johnson & Johnson in Q4 2021 and held it in 15 quarters.
  • ASB Consultores's Johnson & Johnson position peaked at $1.46M in Q2 2023.
  • 4,187 funds tracked by Wall St. Rank held Johnson & Johnson as of Q3 2025.

Based on ASB Consultores's 13F filing for Q3 2025, filed 4 Nov 2025.